Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials (Galvano et al., J Bone Oncol 2019; 18:100252)
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 103
(17)
◽
pp. 1299-1309
◽